These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8863666)

  • 1. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.
    Wu PC; Fang JW; Lau VK; Lai CL; Lo CK; Lau JY
    Am J Pathol; 1996 Oct; 149(4):1167-75. PubMed ID: 8863666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma.
    Aishima S; Nishihara Y; Kuroda Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 May; 31(5):783-91. PubMed ID: 17460464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
    Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N
    Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of biliary antigen and its clinical significance in hepatocellular carcinoma.
    Yoon DS; Jeong J; Park YN; Kim KS; Kwon SW; Chi HS; Park C; Kim BR
    Yonsei Med J; 1999 Oct; 40(5):472-7. PubMed ID: 10565259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors.
    Ng IO; Ng M; Fan ST
    Am J Gastroenterol; 1997 Aug; 92(8):1355-8. PubMed ID: 9260806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
    Nanashima A; Yano H; Yamaguchi H; Tanaka K; Shibasaki S; Sumida Y; Sawai T; Shindou H; Nakagoe T
    J Gastroenterol; 2004; 39(2):148-54. PubMed ID: 15069621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
    Osada S; Saji S; Kuno T
    J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of proliferating cell nucleus antigen and nm23 protein and their relation with metastasis in hepatocellular carcinoma].
    Luo HY; Wang HC; Feng DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):17-9. PubMed ID: 12934386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
    Wells SJ; DeRose PB; Cohen C
    Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary liver carcinoma arising in people younger than 30 years.
    Klein WM; Molmenti EP; Colombani PM; Grover DS; Schwarz KB; Boitnott J; Torbenson MS
    Am J Clin Pathol; 2005 Oct; 124(4):512-8. PubMed ID: 16146811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
    Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
    Lee RG; Tsamandas AC; Demetris AJ
    Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
    Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
    Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
    Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
    Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
    Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
    Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.